Improving medication adherence in atrial fibrillation
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a program that uses WeChat messages to help people with atrial fibrillation remember to take their blood-thinner medication. The goal is to see if reminding people to think about future benefits (things they look forward to) improves how regularly they take their medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation (an irregular heartbeat) that is stable and under control
- You are at least 18 years old
- You are currently taking, or have taken, an oral blood thinner (such as warfarin or apixaban)
- You can use the WeChat mobile app
- You do not have severe problems with your major organs (like heart, liver, or kidneys), serious vision or hearing problems, or cognitive or psychiatric conditions that would interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether text message reminders can help people with atrial fibrillation take their blood thinner medication more consistently. If you have atrial fibrillation and take a blood thinner, this could help you stay on track with your treatment.
This trial tests a mobile education program on a smartphone to help you learn about and manage your atrial fibrillation. If found helpful, it could improve your symptoms and quality of life.
This study looks at how well patients with atrial fibrillation or heart failure take their heart medications while in the coronary care unit. By understanding this, doctors can better support patients to stay on track with their treatment.
This trial tests an AI-guided approach to treating atrial fibrillation (AF), a heart rhythm problem. It aims to personalize your treatment plan to better manage symptoms and improve outcomes.
This study uses a smartwatch to track your heart and look for changes in your atrial fibrillation (irregular heartbeat) over time. It aims to learn more about how the condition progresses and the risk of stroke or blood clots, which may help improve future care.
This study tests whether using a smartwatch to track how much time your heart is in AFib each day can help guide treatment. It aims to see if keeping AFib episodes low leads to better outcomes.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.